Jump to content

Molecular risk assessment

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by RileyBot (talk | contribs) at 23:36, 22 February 2013 (→‎External links: Bot: Updating URL for www.cancer.gov per site update) (Task 7). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Molecular risk assessment is a procedure in which biomarkers (for example, biological molecules or changes in tumor cell DNA) are used to estimate a person’s risk for developing cancer. Specific biomarkers may be linked to particular types of cancer.

Sources

Public Domain This article incorporates public domain material from Dictionary of Cancer Terms. U.S. National Cancer Institute.